Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Would someone pay $ 2B for DIMI?

<< Previous

Bullboard Posts

Next >>

Comment by hmmmmmmmmon Feb 09, 2022 2:25pm

153 Views

Post# 34413600

RE:RE:RE:Would someone pay $ 2B for DIMI?

And we already know they are trying out a similar partnership with Baxter's peritoneal machine- why wouldn't this colab work well centered around the real deal, disruptive DIMI machine.
Strength + strength + strength.

Baxter could also peel off the SAMI portion for hospital use.

You have to wonder what the math starts looking like for Baxter if the DIMI trial top line numbers and PMX 60% come in around the same time..

<< Previous

Bullboard Posts

Next >>

Drilling underway at a large copper-moly porphyry target in Peru